Sign Up to like & get
recommendations!
4
Published in 2023 at "Biomedicines"
DOI: 10.3390/biomedicines11030780
Abstract: Stroke is a leading cause of death, long-term disability, and socioeconomic costs, highlighting the urgent need for effective treatment. During acute phase, intravenous administration of recombinant tissue plasminogen activator (tPA), a thrombolytic agent, and endovascular…
read more here.
Keywords:
time window;
nanotechnology;
agent;
stroke new ... See more keywords